Key Findings:  Complexes formed of a variety of sub-units (heteromers) such as GPR55 and CB1/CB2 receptor sites in the striatum of parkinsonian macaques (with and without levodopa-induced dyskinesia) show an increased expression. As such, the author posit the potential for novel non-dopaminergic targets for PD therapy.
Type of Study:  Animal Study
Study Result:  Positive
Cannabinoids Studied:  Not Applicable
Phytocannabinoid Source:  Not Applicable